Further, we propose that Krüppel‐like factor 5 (KLF5), the downstream effector of this pathway, promotes cisplatin/oxaliplatin resistance supporting metastasis in colorectal cancer patients. The gene discussed is KLF5; the disease is colorectal cancer.